This report reviews the Access to Medicine Index (AMTi) in positively changing the pharmaceutical industry.  This report notes a number of opportunities for the ATMi to improve its engagement with stakeholders.  The current level of engagement between the ATMf and stakeholders, at least on a public level, is not strong.  Consistent with the values the ATMi desires to encourage across the pharmaceutical sector, it must also espouse greater levels of objectivity, accountability, transparency and collaboration in order to further contribute to addressing the challenge of access to essential medicines